Novel progranulin mutation: Screening for PGRN mutations in a Portuguese series of FTD/CBS cases

Movement Disorders

Volumn 23, Issue 9, 2008, Pages 1269-1273

  Guerreiro, Rita Joao ^a,b   Santana, Isabel ^c   Bras, Jose Miguel ^a,b   Revesz, Tamas ^d   Rebelo, Olinda ^c   Ribeiro, Maria Helena ^b   Santiago, Beatriz ^c   Oliveira, Catarina Resende ^b,c   Singleton, Andrew ^a   Hardy, John ^a,d  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Corti cobasal syndrome; Frontotemporal dementia; Portuguese population; Progranulin

Indexed keywords

PROGRANULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; EXON; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE FREQUENCY; GENE INSERTION; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRON; MALE; PATHOGENICITY; POINT MUTATION; PORTUGAL; PRIORITY JOURNAL;

DEMENTIA; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; FAMILY HEALTH; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MUTATION; PORTUGAL;

EID: 51449107701     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22078     Document Type: Article

References (23)

1. The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994;57:416-418.
2. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1554.
3. Baker M, Mackenzie IR, Pickering-Brown SM, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006;442:916-919.
4. Cruts M, Gijselinck I, van der Zee J, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006;442:920-924.
5. Cruts M, Kumar-Singh S, Van Broeckhoven C. Progranulin mutations in ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Curr Alzheimer Res 2006;3:485-491.
6. Gass J, Cannon A, Mackenzie IR, et al. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet 2006;15:2988-3001.
7. Bronner IF, Rizzu P, Seelaar H, et al. Progranulin mutations in Dutch familial frontatemporal lobar degeneration. Ent J Hum Genet 2007;15:369-374.
8. van der Zee J, Le Ber I, Maurer-Stroh S, et al. Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia. Hum Mutat 2007;28:416.
9. Goedert M, Spillantini MG. Frontotemporal lobar degeneration through loss of progranulin function. Brain 2006;129:2808-2810.
10. Mackenzie IR, Baker M, Pickering-Brown S, et al. The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Brain 2006;129:3081-3090.
11. Neumann M, Kwong LK, Truax AC, et al. TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions. J Neuropathol Exp Neurol 2007;66: 177-183.
12. Schymick J, Yang Y, Andersen P, et al. Progranulin mutations and ALS or ALS-FTD phenotypes. J Neurol Neurosurg Psychiatry 2007;78:754-756.
13. Llado A, Sanchez-Valle R, Rene R, et al. Late-onset frontotemporal dementia associated with a novel PGRN mutation. J Neural Transm 2007;114:1051-1054.
14. Van Deerlin VM, Wood EM, Moore P, et al. Clinical, genetic, and pathologic characteristics of patients with frontotemporal dementia and progranulin mutations. Arch Neurol 2007;64:1148-1153.
15. Masellis M, Momeni P, Meschino W, et al. Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome. Brain 2006;129:3115-3123.
16. Benussi L, Binetti G, Sina. E, et al. A novel deletion in progranulin gene is associated with FTDP-17 and CBS, Neurobiol Aging 2006;29:427-435.
17. Josephs KA, Ahmed Z, Katsuse O, et al. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations. J Neuropathol Exp Neurol 2007;66:142-151.
18. Josephs KA, Holton JL, Rossor MN, et al. Frontotemporal lobar degeneration and ubiquitin immunohistochemistry. Neuropathol Appl Neurobiol 2004;30:369-373.
19. Sampathu DM, Neumann M, Kwong LK, et al, Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. Am J Pathol 2006;169:1343-1352.
20. Mackenzie IR, Baborie A, Pickering-Brown S, et al. Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype. Acta Neuropathol (Berl) 2006;112:539-549.
21. Ince PG, Clark B, Holton JL, Revesz T, Whatley W. Disorders of movement and system degenerations. In: Ellison DW, Louis, DN, Love, S, editors. Greenfield's Neuropathology. Arnold: London (in press).
22. Grimes DA, Bergeron CB, Lang AE. Motor neuron disease-inclusion dementia presenting as cortical-basal ganglionic degeneration. Mov Disord 1999;14:674-680.
23. Paviour DC, Lees AJ, Josephs KA, et al. Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes: broadening the clinical picture to include progressive supranuclear palsy. Brain 2004;127:2441-2451.